Cargando…

Assessment of Liaison XL Murex Chagas diagnostic performance in blood screening for Chagas disease using a reference array of chimeric antigens

BACKGROUND: Chagas disease (CD) serological screening at blood banks is usually performed by a single highly sensitive serological assay, with chemiluminescent immunoassays (CLIAs) being the method of choice. CLIAs employ recombinant, fusion peptides and/or chimeric antigens that selectively capture...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos, Emily F., Leony, Leonardo M., Silva, Ângelo A. O., Daltro, Ramona T., Freitas, Natália E. M., Vasconcelos, Larissa C. M., de Araújo, Fernando L. V., Celedon, Paola A. F., Krieger, Marco A., Zanchin, Nilson I. T., Santos, Fred L. N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Donor Infectious Disease Testing
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292309/ https://www.ncbi.nlm.nih.gov/pubmed/34240750 http://dx.doi.org/10.1111/trf.16583

Ejemplares similares

Evidence of likely autochthonous Chagas disease in the southwestern United States: A case series of Trypanosoma cruzi seropositive blood donors
por: Lynn, Mary K., et al.
Publicado: (2022)

Stability Assessment of Four Chimeric Proteins for Human Chagas Disease Immunodiagnosis
por: Celedon, Paola Alejandra Fiorani, et al.
Publicado: (2021)

Western blot using Trypanosoma cruzi chimeric recombinant proteins for the serodiagnosis of chronic Chagas disease: A proof-of-concept study
por: Daltro, Ramona Tavares, et al.
Publicado: (2022)

Performance of Chimeric Trypanosoma cruzi Antigens in Serological Screening for Chagas Disease in Blood Banks
por: dos Santos, Emily Ferreira, et al.
Publicado: (2022)

Development of a New Lateral Flow Assay Based on IBMP-8.1 and IBMP-8.4 Chimeric Antigens to Diagnose Chagas Disease
por: Silva, Edimilson D., et al.
Publicado: (2020)

Accuracy of chimeric proteins in the serological diagnosis of chronic chagas disease – a Phase II study
por: Santos, Fred Luciano Neves, et al.
Publicado: (2017)

COVID‐19 antibody screening with SARS‐CoV‐2 red cell kodecytes using routine serologic diagnostic platforms
por: Nagappan, Radhika, et al.
Publicado: (2021)

Serologic screening of United States blood donors for Babesia microti using an investigational enzyme immunoassay
por: Levin, Andrew E., et al.
Publicado: (2016)

Economic implications of FDA platelet bacterial guidance compliance options: Comparison of single‐step strategies
por: Prioli, Katherine M., et al.
Publicado: (2022)

Acquired platelet storage container leaks and contamination with environmental bacteria: A preventable cause of bacterial sepsis
por: Gammon, Richard R., et al.
Publicado: (2021)

Evaluation of a new West Nile virus nucleic acid test for screening of blood donations
por: Stanley, Jean, et al.
Publicado: (2018)

Longitudinal analysis of SARS‐CoV‐2 antibodies in 8000 U.S. first‐time convalescent plasma donations
por: Karbiener, Michael, et al.
Publicado: (2021)

Duplex nucleic acid test for the detection of chikungunya and dengue RNA viruses in blood donations
por: Stramer, Susan L., et al.
Publicado: (2019)

Detection of dengue, chikungunya, and Zika RNA in blood donors from Southeast Asia
por: Stanley, Jean, et al.
Publicado: (2020)

Detection of Babesia RNA and DNA in whole blood samples from US blood donations
por: Stanley, Jean, et al.
Publicado: (2021)

Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay
por: Levin, Andrew E, et al.
Publicado: (2014)

Detection of anti-Trypanosoma cruzi antibodies by chimeric antigens in chronic Chagas disease-individuals from endemic South American countries
por: Del-Rei, Rodrigo Pimenta, et al.
Publicado: (2019)

High prevalence of human T‐cell leukemia virus type‐1b genotype among blood donors in Gabon, Central Africa
por: Ramassamy, Jill‐Léa, et al.
Publicado: (2020)

Prevalence of DNA of fourteen human polyomaviruses determined in blood donors
por: Kamminga, Sergio, et al.
Publicado: (2019)

A WHO tool for risk‐based decision making on blood safety interventions
por: Janssen, Mart P., et al.
Publicado: (2020)

Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program
por: Wendel, Silvano, et al.
Publicado: (2020)

Performance profile of an updated safety measure rapid assay for bacteria in platelets
por: Vallejo, Remo P., et al.
Publicado: (2020)

Trends and risk factors of SARS‐CoV‐2 infection in asymptomatic blood donors
por: Valenti, Luca, et al.
Publicado: (2021)

A novel competition ELISA for the rapid quantification of SARS‐CoV‐2 neutralizing antibodies in convalescent plasma
por: Wouters, Elise, et al.
Publicado: (2021)

Human T‐lymphotropic virus in Irish blood donors: Impact on future testing strategy
por: Williams, Pádraig, et al.
Publicado: (2022)

Evaluation of an improved rapid bacterial assay with untreated and pathogen‐reduced platelets: Detection of Acinetobacter strains
por: LaVerda, David, et al.
Publicado: (2021)

Highly Accurate Chimeric Proteins for the Serological Diagnosis of Chronic Chagas Disease: A Latent Class Analysis
por: Santos, Fred Luciano Neves, et al.
Publicado: (2018)

Cross-Reactivity Using Chimeric Trypanosoma cruzi Antigens: Diagnostic Performance in Settings Where Chagas Disease and American Cutaneous or Visceral Leishmaniasis Are Coendemic
por: Daltro, Ramona Tavares, et al.
Publicado: (2019)

Performance Assessment of Four Chimeric Trypanosoma cruzi Antigens Based on Antigen-Antibody Detection for Diagnosis of Chronic Chagas Disease
por: Santos, Fred Luciano Neves, et al.
Publicado: (2016)

Immune reactivity to Trypanosoma cruzi chimeric proteins for Chagas disease diagnosis in immigrants living in a non-endemic setting
por: Dopico, Eva, et al.
Publicado: (2019)

Seroepidemiological Survey of Chronic Chagas Disease in a Rural Community in Southern Bahia, Brazil, Using Recombinant Chimeric Antigens
por: Soares, Neci Matos, et al.
Publicado: (2023)

Acute Chagas disease in Brazil from 2001 to 2018: A nationwide spatiotemporal analysis
por: Santos, Emily F., et al.
Publicado: (2020)

Double-antigen sandwich ELISA based on chimeric antigens for detection of antibodies to Trypanosoma cruzi in human sera
por: Freitas, Natália Erdens Maron, et al.
Publicado: (2022)

The first complete mitochondrial genome of Murex from Murex trapa (Neogastropoda: Muricidae)
por: Zhong, Shengping, et al.
Publicado: (2019)

Assessment of Cross-Reactivity of Chimeric Trypanosoma cruzi Antigens with Crithidia sp. LVH-60A: Implications for Accurate Diagnostics
por: Santos, Emily F., et al.
Publicado: (2023)

Cross-sectional, descriptive study of Chagas disease among citizens of Bolivian origin living in Munich, Germany
por: Navarro, Miriam, et al.
Publicado: (2017)

Chagas Disease
por: Tustin, Aaron W., et al.
Publicado: (2016)

Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies
por: Law, Arjun Datt, et al.
Publicado: (2018)

Cell Therapy in Chagas Disease
por: Campos de Carvalho, Antonio C., et al.
Publicado: (2009)

Knowledge, behaviour and attitudes towards Chagas disease among the Bolivian migrant population living in Japan: a cross-sectional study
por: Iglesias Rodríguez, Inés María, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9i07cto4k5kn1tv9ovlactjiji